Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Pharma
AbbVie notches FDA nod for Ceverel asset Juvmo in Parkinson's
Through a trial setback looms in the background, AbbVie’s $8.7 billion bet on Cerevel Therapeutics has paid off with its first approval from the FDA.
Fraiser Kansteiner
Sep 28, 2026 8:15am
Acadia boosts ‘More To Parkinson's’ campaign
May 26, 2026 8:39am
Bial launches ‘Dialogues with Parkinson’s’ campaign
Apr 10, 2026 9:23am
FDA flags seizure risk tied to common Parkinson's meds
Mar 23, 2026 11:39am
Merz steps into the ring with Muhammad Ali-inspired Inbrija push
Feb 5, 2026 9:50am
Supernus confronts Onapgo supply constraint early into launch
Nov 5, 2025 4:20pm
